BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 12436529)

  • 21. Mitochondrial potassium and chloride channels.
    Kicińska A; D bska G; Kunz W; Szewczyk A
    Acta Biochim Pol; 2000; 47(3):541-51. PubMed ID: 11310958
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Anti-ischemic tolerance and preconditioning].
    Miura T; Nakamura Y
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():142-7. PubMed ID: 12734967
    [No Abstract]   [Full Text] [Related]  

  • 23. Upstream signaling of protein kinase C-epsilon in xenon-induced pharmacological preconditioning. Implication of mitochondrial adenosine triphosphate dependent potassium channels and phosphatidylinositol-dependent kinase-1.
    Weber NC; Toma O; Damla H; Wolter JI; Schlack W; Preckel B
    Eur J Pharmacol; 2006 Jun; 539(1-2):1-9. PubMed ID: 16716295
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic potential of ischaemic preconditioning.
    Edwards RJ; Saurin AT; Rakhit RD; Marber MS
    Br J Clin Pharmacol; 2000 Aug; 50(2):87-97. PubMed ID: 10930960
    [No Abstract]   [Full Text] [Related]  

  • 25. Activation of adenosine triphosphate-regulated potassium channels: mediation of cellular and organ protection.
    Kersten JR; Gross GJ; Pagel PS; Warltier DC
    Anesthesiology; 1998 Feb; 88(2):495-513. PubMed ID: 9477071
    [No Abstract]   [Full Text] [Related]  

  • 26. Ischemic preconditioning and adenosine release.
    Lasley RD
    Circulation; 1993 Sep; 88(3):1354; author reply 1359-60. PubMed ID: 8353897
    [No Abstract]   [Full Text] [Related]  

  • 27. Do ATP-sensitive potassium channels play a role in myocardial stunning?
    Gross GJ
    Basic Res Cardiol; 1995; 90(4):266-8. PubMed ID: 8534242
    [No Abstract]   [Full Text] [Related]  

  • 28. Are ischemic stunning, conditioning, and "takotsubo" different sides to the same coin?
    Redfors B; Shao Y; Ali A; Omerovic E
    Int J Cardiol; 2014 Mar; 172(2):490-1. PubMed ID: 24491859
    [No Abstract]   [Full Text] [Related]  

  • 29. Through the looking glass: a positive inotropic drug and ischemic preconditioning.
    Vander Heide RS; Marsh JD
    Circulation; 1997 Apr; 95(8):1989-91. PubMed ID: 9133503
    [No Abstract]   [Full Text] [Related]  

  • 30. [Progressive postischemic dysfunction: stunning, preconditioning, hibernation, and confusion].
    García-Dorado D; Barrabés JA
    Rev Esp Cardiol; 1997 Apr; 50(4):260-1. PubMed ID: 9235609
    [No Abstract]   [Full Text] [Related]  

  • 31. Salvage of jeopardized myocardium by ischemic preconditioning: is the quest over?
    Strasser R; Htun P; Schaper W
    Mol Cell Biochem; 1996; 160-161():209-15. PubMed ID: 8901475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Invited commentary.
    Vinten-Johansen J
    Ann Thorac Surg; 2011 Nov; 92(5):1732-3. PubMed ID: 22051268
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardioprotection by adenosine: is it a question of effective dose, timing, or the target compartment?
    Vinten-Johansen J; Hammon JW
    J Thorac Cardiovasc Surg; 1996 Jul; 112(1):202-4. PubMed ID: 8691875
    [No Abstract]   [Full Text] [Related]  

  • 34. Heat shock proteins: the search for functions.
    Schlesinger MJ
    J Cell Biol; 1986 Aug; 103(2):321-5. PubMed ID: 2426277
    [No Abstract]   [Full Text] [Related]  

  • 35. The species concept.
    BURMA BH; MAYR E
    Evolution; 1949 Dec; 3(4):369-73. PubMed ID: 15396753
    [No Abstract]   [Full Text] [Related]  

  • 36. [Ischemic preconditioning: its concept and mechanism].
    Miura T; Sakamoto J
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):207-13. PubMed ID: 12436529
    [No Abstract]   [Full Text] [Related]  

  • 37. Ischemic preconditioning against infarction: its mechanism and clinical implications.
    Miura T; Miki T; Tsuchihashi K; Iimura O
    EXS; 1996; 76():365-82. PubMed ID: 8805806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ischemic preconditioning.
    Schwarz ER; Whyte WS; Kloner RA
    Curr Opin Cardiol; 1997 Sep; 12(5):475-81. PubMed ID: 9352175
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The role of adenosine in "ischemic preconditioning"].
    Schaper W; Vogt A; Htun P
    Z Kardiol; 1996; 85 Suppl 6():185-90. PubMed ID: 9064964
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Myocardial protection from ischemic damage: effects of preconditioning and pharmacologic activation of KATP channels].
    Galiè N; Ussia GP; Catanzariti P; Grigioni F; Parlangeli R; Serafini F; Uguccioni L; Branzi A; Magnani B
    Cardiologia; 1995 Dec; 40(12 Suppl 1):77-82. PubMed ID: 8998785
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.